8246 related articles for article (PubMed ID: 12500936)
1. Doxycycline-inducible expression of SPARC/Osteonectin/BM40 in MDA-MB-231 human breast cancer cells results in growth inhibition.
Dhanesuan N; Sharp JA; Blick T; Price JT; Thompson EW
Breast Cancer Res Treat; 2002 Sep; 75(1):73-85. PubMed ID: 12500936
[TBL] [Abstract][Full Text] [Related]
2. cDNA array analysis of SPARC-modulated changes in glioma gene expression.
Golembieski WA; Rempel SA
J Neurooncol; 2002 Dec; 60(3):213-26. PubMed ID: 12510773
[TBL] [Abstract][Full Text] [Related]
3. SPARC modulates cell growth, attachment and migration of U87 glioma cells on brain extracellular matrix proteins.
Rempel SA; Golembieski WA; Fisher JL; Maile M; Nakeff A
J Neurooncol; 2001 Jun; 53(2):149-60. PubMed ID: 11716067
[TBL] [Abstract][Full Text] [Related]
4. Endogenous osteonectin/SPARC/BM-40 expression inhibits MDA-MB-231 breast cancer cell metastasis.
Koblinski JE; Kaplan-Singer BR; VanOsdol SJ; Wu M; Engbring JA; Wang S; Goldsmith CM; Piper JT; Vostal JG; Harms JF; Welch DR; Kleinman HK
Cancer Res; 2005 Aug; 65(16):7370-7. PubMed ID: 16103089
[TBL] [Abstract][Full Text] [Related]
5. SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines.
Gilles C; Bassuk JA; Pulyaeva H; Sage EH; Foidart JM; Thompson EW
Cancer Res; 1998 Dec; 58(23):5529-36. PubMed ID: 9850090
[TBL] [Abstract][Full Text] [Related]
6. Effects of the matricellular protein SPARC on human retinal pigment epithelial cell behavior.
Hagan S; Hiscott P; Sheridan CM; Wong D; Grierson I; McGalliard J
Mol Vis; 2003 Mar; 9():87-92. PubMed ID: 12655283
[TBL] [Abstract][Full Text] [Related]
7. SPARC (secreted protein acidic and rich in cysteine) induces apoptosis in ovarian cancer cells.
Yiu GK; Chan WY; Ng SW; Chan PS; Cheung KK; Berkowitz RS; Mok SC
Am J Pathol; 2001 Aug; 159(2):609-22. PubMed ID: 11485919
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of motility of human renal cell carcinoma by SPARC/Osteonectin/BM-40 associated with type IV collagen.
Kato Y; Sakai N; Baba M; Kaneko S; Kondo K; Kubota Y; Yao M; Shuin T; Saito S; Koshika S; Kawase T; Miyagi Y; Aoki I; Nagashima Y
Invasion Metastasis; 1998-1999; 18(2):105-14. PubMed ID: 10364690
[TBL] [Abstract][Full Text] [Related]
9. Methylation-mediated expression of SPARC is correlated with tumor progression and poor prognosis of breast cancer.
Li XL; Li JL; Qiu DJ; Ma L
Neoplasma; 2022 Jul; 69(4):794-806. PubMed ID: 35400166
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of SPARC expression inhibits cell migration and invasion in malignant gliomas.
Seno T; Harada H; Kohno S; Teraoka M; Inoue A; Ohnishi T
Int J Oncol; 2009 Mar; 34(3):707-15. PubMed ID: 19212676
[TBL] [Abstract][Full Text] [Related]
11. Secreted Protein Acidic and Rich in Cysteine (SPARC) Enhances Cell Proliferation, Migration, and Epithelial Mesenchymal Transition, and SPARC Expression is Associated with Tumor Grade in Head and Neck Cancer.
Chang CH; Yen MC; Liao SH; Hsu YL; Lai CS; Chang KP; Hsu YL
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28718842
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of SPARC obliterates the in vivo tumorigenicity of human hepatocellular carcinoma cells.
Atorrasagasti C; Malvicini M; Aquino JB; Alaniz L; Garcia M; Bolontrade M; Rizzo M; Podhajcer OL; Mazzolini G
Int J Cancer; 2010 Jun; 126(11):2726-40. PubMed ID: 19830689
[TBL] [Abstract][Full Text] [Related]
13. A study of SPARC and vitronectin localization and expression in pediatric and adult gliomas: high SPARC secretion correlates with decreased migration on vitronectin.
Menon PM; Gutierrez JA; Rempel SA
Int J Oncol; 2000 Oct; 17(4):683-93. PubMed ID: 10995878
[TBL] [Abstract][Full Text] [Related]
14. SPARC enhances tumor stroma formation and prevents fibroblast activation.
Chlenski A; Guerrero LJ; Yang Q; Tian Y; Peddinti R; Salwen HR; Cohn SL
Oncogene; 2007 Jul; 26(31):4513-22. PubMed ID: 17260013
[TBL] [Abstract][Full Text] [Related]
15. SPARC affects glioma cell growth differently when grown on brain ECM proteins in vitro under standard versus reduced-serum stress conditions.
Vadlamuri SV; Media J; Sankey SS; Nakeff A; Divine G; Rempel SA
Neuro Oncol; 2003 Oct; 5(4):244-54. PubMed ID: 14565160
[TBL] [Abstract][Full Text] [Related]
16. Gamma-Linolenic acid regulates the expression and secretion of SPARC in human cancer cells.
Watkins G; Martin TA; Bryce R; Mansel RE; Jiang WG
Prostaglandins Leukot Essent Fatty Acids; 2005 Apr; 72(4):273-8. PubMed ID: 15763439
[TBL] [Abstract][Full Text] [Related]
17. Increased levels of SPARC (osteonectin) in human breast cancer tissues and its association with clinical outcomes.
Watkins G; Douglas-Jones A; Bryce R; Mansel RE; Jiang WG
Prostaglandins Leukot Essent Fatty Acids; 2005 Apr; 72(4):267-72. PubMed ID: 15763438
[TBL] [Abstract][Full Text] [Related]
18. SPARC suppresses lymph node metastasis by regulating the expression of VEGFs in ovarian carcinoma.
Peng F; Zhong Y; Liu Y; Zhang Y; Xie Y; Lu Y; Zhang X; Li D
Int J Oncol; 2017 Dec; 51(6):1920-1928. PubMed ID: 29075785
[TBL] [Abstract][Full Text] [Related]
19. SPARC expression is associated with impaired tumor growth, inhibited angiogenesis and changes in the extracellular matrix.
Chlenski A; Liu S; Guerrero LJ; Yang Q; Tian Y; Salwen HR; Zage P; Cohn SL
Int J Cancer; 2006 Jan; 118(2):310-6. PubMed ID: 16052522
[TBL] [Abstract][Full Text] [Related]
20. Loss of insulin-like growth factor I receptor-dependent expression of p107 and cyclin A in cells that lack the extracellular matrix protein secreted protein acidic and rich in cysteine.
Basu A; Rodeck U; Prendergast GC; Howe CC
Cell Growth Differ; 1999 Nov; 10(11):721-8. PubMed ID: 10593648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
